Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)

Abstract

Squamous cell carcinoma of the lung is associated with smoking in its development and comprises about 20–30% of all lung cancers. Its treatment strategy had been limited for the past decades, inevitably resulting in the poor outcome. However in the 2010s, it has dramatically changed mainly with the recent clinical introduction of immune checkpoint inhibitors. In this review, we will introduce various clinical studies involving squamous cell carcinoma of the lung.

Original languageEnglish
Pages (from-to)461-467
Number of pages7
JournalInternational Journal of Clinical Oncology
Volume24
Issue number5
DOIs
Publication statusPublished - May 15 2019
Externally publishedYes

Keywords

  • Cytotoxic drug
  • Immune checkpoint inhibitor
  • Squamous cell carcinoma of the lung

ASJC Scopus subject areas

  • Surgery
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan'. Together they form a unique fingerprint.

Cite this